Ophthalmology

Top Story

Half-dose verteporfin PDT increases visual acuity, reduces recurrence in central serous chorioretinopathy

Half-dose verteporfin PDT increases visual acuity, reduces recurrence in central serous chorioretinopathy
May 31, 2016

COLORADO SPRINGS, Colo. — Photodynamic therapy with half-dose verteporfin significantly increased visual acuity in eyes with central serous chorioretinopathy compared with that in untreated controls, according to a study presented here.

Furthermore, recurrence was significantly less likely to occur in treated patients during the follow-up (P < .001), Timothy Y.Y. Lai, MD, said in a presentation of his thesis paper to the American Ophthalmological Society.

CommentaryFrom OSN APAO

Phakic IOLs useful tool to correct refractive error in cases not amenable to excimer laser surgery

Ocular Surgery News APAO Edition, May 2016
Bhaskar Srinivasan, MD; Dennis S.C. Lam, MD, FRCOphth
LASIK is the most common refractive surgery performed worldwide. Some patients, however, are not suitable candidates for excimer laser refractive surgery due to high…
From OSN Europe

Ophthalmology community mourns loss of Peter Barry, pillar of ESCRS

May 31, 2016
Peter Barry, FRCS , an outstanding member of the European ophthalmology community and lead author of the pivotal ESCRS study on endophthalmitis…
From OSN Europe

Moria releases new endothelial graft guarded punch

May 31, 2016
Moria announced the release of a single-use donor vacuum guarded punch for endothelial graft preparation.The device has a 350-µm guarded blade designed to score…
Meeting News CoverageFrom OSN Europe

Long-term experience with light therapy in dry eye shows positive outcomes, patient satisfaction

May 31, 2016
MILAN — Long-term experience with light technologies shows that they are effective in treating meibomian gland dysfunction and dry eye disease. “Light is…
More News Headlines »
Original Article

Prospective Evaluation of Photoscreeners in the Pseudophakic Eyes of Children

Journal of Pediatric Ophthalmology and Strabismus, May/June 2016, Volume 53 Issue 3
To compare refractive data of Plusoptix AO9 (Plusoptix, Inc., Atlanta, GA) and Spot (Welch Allyn, Skaneateles Falls…
More »
CME

Conducting Macular Clinical Trials in a Private Practice Environment

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: Surgeon discusses iris suspension devices for small pupils

May 29, 2016
More »
morganatic-roan
morganatic-roan